On October 23, filming crews from TV BRICS and Almaty TV visited the Zhongguancun Life Science Park in Beijing's Changping District to discover the latest innovations in the city's life sciences and biomanufacturing fields.

At the Zhongguancun Life Science Park exhibition hall, the crews gained a comprehensive understanding of the park's development history, functional layout, and key enterprises, while viewing achievements from Beijing's pharmaceutical and health industry cluster.

The exhibition hall, through rich graphics and interactive content, showcased groundbreaking progress in areas such as innovative drugs, medical devices, and synthetic biology. It also highlighted the park's success in promoting the transformation of scientific and technological achievements and fostering an innovation ecosystem.

The Zhongguancun Life Science Park is a key component of the Future Science City in Changping District, Beijing. The park focuses on medical and pharmaceutical technologies, synthetic biology manufacturing, and medical devices, and has attracted more than 2,000 entities in the pharmaceutical and health industries. Centered around the Life Science Park, Changping's biopharmaceutical enterprises have flourished, with 322 national high-tech enterprises, 192 specialized and sophisticated enterprises, and 23 unicorn or potential unicorn companies. In the first half of 2025, large-scale pharmaceutical and health enterprises in Changping District achieved a revenue of 50.32 billion yuan ($7.08 billion), up 9.7 percent year-on-year. Their output value reached 21.83 billion yuan, a 12.2 percent increase, demonstrating strong industrial growth momentum.